Third Point has 11.4% stake in Nabi Biopharmaceuticals

By Lisa Kerner

Charlotte, N.C., May 11 - Nabi Biopharmaceuticals investors led by Third Point LLC purchased 1,494,400 shares of the company's stock between May 8 and May 10 priced from $5.13 to $5.25 per share, according to a schedule 13D filing with the Securities and Exchange Commission.

The investors beneficially own 6,890,000 shares, or 11.4%, of the Boca Raton, Fla., pharmaceutical company's outstanding stock.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.